BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11870379)

  • 1. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts.
    Neil DA; Hubscher SG
    Hepatology; 2002 Mar; 35(3):639-51. PubMed ID: 11870379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema.
    Sebagh M; Blakolmer K; Falissard B; Roche B; Emile JF; Bismuth H; Samuel D; Reynès M
    Hepatology; 2002 Jan; 35(1):117-25. PubMed ID: 11786967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection.
    Demirhan B; Bilezikçi B; Haberal AN; Sevmiş S; Arat Z; Haberal M
    Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
    Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
    Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine.
    Lovell MO; Speeg KV; Havranek RD; Sharkey FE
    Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome.
    Hassoun Z; Shah V; Lohse CM; Pankratz VS; Petrovic LM
    Liver Transpl; 2004 Apr; 10(4):480-7. PubMed ID: 15048789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C.
    Souza P; Prihoda TJ; Hoyumpa AM; Sharkey FE
    Hum Pathol; 2009 Jan; 40(1):92-7. PubMed ID: 18790517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell hyperplasia in chronic rejection after liver transplantation.
    O'Keeffe C; Baird AW; Nolan N; McCormick PA
    Liver Transpl; 2002 Jan; 8(1):50-7. PubMed ID: 11799486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients.
    Sundaram SS; Melin-Aldana H; Neighbors K; Alonso EM
    Liver Transpl; 2006 Jan; 12(1):58-64. PubMed ID: 16382471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can early liver biopsies predict long-term outcome of the graft?
    Petrovic LM
    Liver Transpl; 2003 Jan; 9(1):99-100. PubMed ID: 12514780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of late acute rejection episodes on long-term graft outcome after liver transplantation.
    Junge G; Tullius SG; Klitzing V; Schewior L; Pratschke J; Radke C; Neuhaus R; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1716-7. PubMed ID: 15919442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection.
    Neff GW; Montalbano M; Slapak-Green G; Berney T; Bejarano PA; Joshi A; Icardi M; Nery J; Seigo N; Levi D; Weppler D; Pappas P; Ruiz J; Schiff ER; Tzakis AG
    Liver Transpl; 2003 May; 9(5):477-83. PubMed ID: 12740790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection.
    Matsumoto Y; McCaughan GW; Painter DM; Bishop GA
    Transplantation; 1993 Jul; 56(1):69-75. PubMed ID: 8333070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients.
    Nakazawa Y; Walker NI; Kerlin P; Steadman C; Lynch SV; Strong RW; Clouston AD
    Transplantation; 2000 Apr; 69(8):1599-608. PubMed ID: 10836369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers.
    Krasinskas AM; Demetris AJ; Poterucha JJ; Abraham SC
    Liver Transpl; 2008 May; 14(5):625-32. PubMed ID: 18433038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
    Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological examination for liver transplantation].
    Nakayama J; Ota H; Katsuyama T; Nakazawa Y; Hashikura Y; Kawasaki S
    Rinsho Byori; 2000 Nov; 48(11):1022-8. PubMed ID: 11132555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.